Clinical trials
Completed trials in Mozambique
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 5 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 108 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centro de Investigacao em Saude de Manhica | 8 |
| Barcelona Institute for Global Health | 6 |
| GlaxoSmithKline | 5 |
| University of Washington | 5 |
| Columbia University | 4 |
| Institut National de la Santé Et de la Recherche Médicale, France | 4 |
| Instituto Nacional de Saúde, Mozambique | 4 |
| University of Cape Town | 4 |
| Vanderbilt University Medical Center | 4 |
| Institute of Tropical Medicine, Belgium | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 33 |
| Tuberculosis | 15 |
| Acquired Immunodeficiency Syndrome | 12 |
| COVID-19 | 8 |
| HIV Infections | 8 |
| Malaria, Falciparum | 6 |
| Disease | 4 |
| Pneumonia | 4 |
| Anemia | 2 |
| Diarrhea | 2 |
Trials
Showing 51 to 75 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.